Institutional Variability in Testing for Actionable Genetic Alterations in Patients with Stage IIIB/C or IV NSCLC: Real-World Data from the Prospective, Multicenter CRISP Registry (AIO-TRK-0315)

15. Januar 2026

F. Althoff, H-D. Hummel, K. Kokowski, C. Elender, C. Grah, M. Jaenicke, A. Fleitz, S. Zacharias, A. Groth, P. Ludwig, A. Nusch, M. Reiser, H. Pelz, J.H. Wiegand, F. Griesinger, M. Thomas, W.E.E. Eberhardt, M. Sebastian, ESMO 2025.

Annals of Oncology, Volume 36, Supplement 2, 2025, Pages S1068-S1069, ISSN 0923-7534, https://doi.org/10.1016/j.annonc.2025.08.2635

Poster